Brief: InDex Pharmaceuticals Q1 EBIT Loss at SEK 44.3 Million

Flerie AB

24/05/2023 07:03

May 24 (Reuters) - InDex Pharmaceuticals Q1 cash flow from operating
activities SEK -23.1 million.
* Q1 sales SEK 0
* Q1 net income SEK -41.8 million
* Q1 EBIT SEK -44.3 million